Improving HIV prevention for drug users on probation in Eastern Europe
Innovations in Implementing Medications for Opioid Use Disorder for HIV Prevention in Probation Settings in Eastern Europe
This study is looking for better ways to help people on probation in Eastern Europe who use drugs stay healthy and prevent HIV, by understanding their needs and finding the best ways to support them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11085528 on NIH RePORTER |
What this research studies
This research focuses on developing effective strategies for implementing medications that help prevent HIV among individuals using drugs who are on probation in Eastern Europe. The project aims to enhance the skills of a sociologist in understanding and addressing the social factors that contribute to HIV risk in this population. By utilizing a combination of qualitative and quantitative research methods, the study will explore how to better engage and treat these individuals through a screening-engagement-treatment strategy. The research will take place in Georgia and Moldova, aiming to adapt interventions to the unique social and epidemiological contexts of these regions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use drugs and are currently on probation in Eastern Europe.
Not a fit: Patients who are not on probation or do not use drugs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV prevention strategies for drug users, ultimately reducing the incidence of HIV in this vulnerable population.
How similar studies have performed: Previous research has shown that tailored interventions for drug users can be effective in reducing HIV risk, suggesting that this approach may also yield positive results.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Azbel, Lyuba — Yale University
- Study coordinator: Azbel, Lyuba
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.